Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $539,529 - $635,103
5,100 Added 57.3%
14,000 $1.62 Million
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $195,912 - $230,813
-1,800 Reduced 16.82%
8,900 $1.07 Million
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $913,500 - $995,454
8,700 Added 435.0%
10,700 $1.17 Million
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $494,856 - $600,966
-5,400 Reduced 72.97%
2,000 $218,000
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $298,623 - $382,200
-3,900 Reduced 34.51%
7,400 $677,000
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $5.94 Million - $8.68 Million
-94,500 Reduced 89.32%
11,300 $892,000
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $3.5 Million - $3.9 Million
44,600 Added 72.88%
105,800 $9.19 Million
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $1.05 Million - $1.14 Million
12,800 Added 26.45%
61,200 $5.12 Million
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $94,744 - $110,500
1,300 Added 2.76%
48,400 $4.07 Million
Q1 2019

May 15, 2019

BUY
$66.22 - $80.06 $6,622 - $8,006
100 Added 0.21%
47,100 $3.77 Million
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $1.64 Million - $1.86 Million
25,000 Added 113.64%
47,000 $3.4 Million
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $10.6 Million - $12.8 Million
-174,200 Reduced 88.79%
22,000 $1.61 Million
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $3.29 Million - $3.63 Million
57,100 Added 41.05%
196,200 $12 Million
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $7.26 Million - $8.21 Million
129,100 Added 1291.0%
139,100 $8.34 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $480,600 - $536,400
10,000
10,000 $534,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $207B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.